Progyny, Inc. (PGNY)
NASDAQ · Healthcare
As of Jul 20, 2026
Price history
Key statistics
- Market cap
- $2.4B
- P/E ratio
- —
- EPS
- —
- Volume
- 664,854
- 52-week high
- —
- 52-week low
- —
- Open
- $31.97
- Day high
- $32.24
- Day low
- $31.50
Financial highlights
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| 2025 | $324.04M | $15.06M | $0.17 |
| 2024 | $278.08M | $16.9M | $0.17 |
| 2023 | $1.09B | $62.04M | $0.62 |
| 2022 | $786.91M | $30.36M | $0.30 |
| 2021 | $500.62M | $65.77M | $0.66 |
About Progyny, Inc.
Progyny, Inc. functions as a benefits management corporation, dedicated to providing specialized solutions for fertility and broader family-building initiatives to employers throughout the United States. Its core fertility offering is characterized by a distinctive benefits plan architecture, paired with personalized, white-glove member support services and access to a meticulously chosen network of top-tier fertility specialists. Additionally, the company presents Progyny Rx, an all-encompassing pharmacy benefits solution that ensures its members can readily acquire the essential medications for their treatments. Moreover, Progyny facilitates employer-sponsored reimbursement programs to support surrogacy and adoption journeys. The company, which was established in 2008 and has its main offices in New York City, previously operated as Auxogyn, Inc. before adopting the Progyny, Inc. moniker in 2015.
- CEO
- David J. Schlanger
- Employees
- 675
- Country
- US
- IPO date
- Oct 25, 2019
Similar stocks
Other Healthcare companies
Frequently asked questions
- What is Progyny, Inc.'s stock price today?
- PGNY is trading at $31.77 as of Jul 20, 2026.
- What is Progyny, Inc.'s market cap?
- Progyny, Inc. (PGNY) has a market capitalization of $2.4B.
- Does Progyny, Inc. pay a dividend?
- Progyny, Inc. did not pay a dividend in its most recent reported fiscal year.
- What sector is Progyny, Inc. in?
- Progyny, Inc. operates in the Healthcare sector.